Scholars Central

Review articlePublished 2012

Duloxetine, a Multitarget Drug

Authors: Priyadarshini K

Advances in Pharmacoepidemiology and Drug Safety

Volume 1 · Issue 4 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

This review presents an overview of the multi targets of the duloxetine drug which was a product of the famous Eli Lilly Company. Although there is little evidence that the studies reproduce, it is clear that different transmitters or receptor types are involved in hyperalgesia and chronic pain which duloxetine mainly targets. While most attention has been focused on neuro transmitters and serotonin-norepinephrine reuptake mechanisms proving the drug efficacy in most discussed aspects. It is mainly known to work by raising the quantity of natural substances, serotonin and norepinephrine in the brain that helps maintaining the mental balance and pause the movement of pain signals in the brain. Any how the side effects are never correlated with the misusage of the drug dosage.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Advances in Pharmacoepidemiology and Drug Safety.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAdvances in Pharmacoepidemiology and Drug Safety
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Priyadarshini K”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels